目標和范圍:《人類疫苗與免疫療法》是唯一一本專注于人類疫苗和免疫療法的同行評審期刊。《華爾街日報》每年出版12期，主要以原創研究文章和評論的形式出版，并以評論和新聞更新為特色。還包括關于一個引起高度興趣的重點主題的文章和評論的專題，以及完全致力于這一主題或著名國際會議文章的專題。該期刊擁有廣泛而杰出的國際編輯委員會成員和副編輯委員會。該雜志從提交到接受再到出版的周轉時間相對較快。人類疫苗與免疫療法(HV&I)為展示和討論疫苗學和免疫療法的前沿研究和發展提供了一個平臺。我們的雜志匯集了在以下領域工作的科學家、醫生、公共衛生從業者和分析人員:研究和開發新的疫苗和免疫療法實驗疫苗和免疫治療的新方法用于治療非傳染性疾病，如癌癥的疫苗和免疫療法臨床前研究和臨床試驗許可產品及其在該領域的使用許可疫苗和免疫療法對疾病的影響許可疫苗的安全性和認知發展中國家的預防和治療流行病學和廣泛HV&I提供多種格式，包括原始研究文章、簡短報告、案例報告、評論和評論。

Aims & Scope: Human Vaccines & Immunotherapeutics is the only peer-reviewed journal focused on vaccines and immunotherapeutics for humans. The journal publishes 12 issues per year, mostly as original research articles and reviews, and also features commentaries and news updates. Also included are Special Features of articles and reviews on a focused theme of high interest as well as Special Issues devoted entirely to one such topic or to articles from prestigious international conferences.The journal is fully indexed with a broad and distinguished international panel of Editorial Board members and Associate Editors Editorial Board. The journal enjoys relatively rapid turnaround time from submission to acceptance to publication.Human Vaccines & Immunotherapeutics (HV&I) provides a platform for presenting and discussing cutting-edge research and developments in vaccinology and immunotherapy. Our journal brings together scientists, physicians, public health practitioners, and analysts working in the areas of: research and development of novel vaccines and immunotherapeutics experimental vaccines and novel approaches in vaccination and immunotherapy vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer preclinical studies and clinical trials licensed products and their use in the field impact of licensed vaccines and Immunotherapeutics on disease safety and perceptions of licensed vaccines prevention and treatment in the developing world epidemiology and pharmaco-economicsHV&I offers a variety of formats including Original Research articles, Short Reports, Case Reports, Reviews, and Commentaries.